The concept of anti-neuronal CD8+ T cell–initiated gray matter injury is supported by the evidence we provide of increased neuronal HLA-A,B,C and β2M expression in the gray matter of MS patients. The gene discussed is B2M; the disease is myeloid sarcoma.